Induction of apoptosis by ginsenoside Rk1 in SK-MEL-2-human melanoma

Archives of Pharmacal Research

Volumn 35, Issue 4, 2012, Pages 717-722

  Kim, Ji Seong ^a   Joo, Eun Ji ^a   Chun, Jaemoo ^a   Ha, Young Wan ^b   Lee, Jue Hee ^c   Han, Yongmoon ^c   Kim, Yeong Shik ^a  

^a Seoul National University   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

^c Dongduk Women's University   (South Korea)

Author keywords

Apoptosis; Ginsenoside Rk1; Mutant p53; SK MEL 2 human melanoma

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ANTINEOPLASTIC AGENT; CASPASE 8; DNA FRAGMENT; FAS LIGAND; GINSENOSIDE; GINSENOSIDE RK 1; PROTEIN BCL 2; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MELANOMA; PROTEIN EXPRESSION; STAINING; WESTERN BLOTTING;

ANTIGENS, CD95; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL SURVIVAL; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FAS LIGAND PROTEIN; FLOW CYTOMETRY; GINSENOSIDES; HUMANS; MELANOMA; MOLECULAR STRUCTURE; PROTO-ONCOGENE PROTEINS C-BCL-2; SKIN NEOPLASMS; TIME FACTORS; UP-REGULATION;

EID: 84862836460     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-012-0416-0     Document Type: Article

References (17)

1. Benchimol, S., p53-dependent pathways of apoptosis. Cell Death Differ., 8, 1049-1051 (2001).
2. Benjamin, C. L. and Ananthaswamy, H. N., p53 and the pathogenesis of skin cancer. Toxicol. Appl. Pharmacol., 224, 241-248 (2007).
3. Chen, J., Peng, H., Ou-Yang, X., and He, X., Research on the antitumor effect of ginsenoside Rg3 in B16 melanoma cells. Melanoma Res., 18, 322-329 (2008).
4. Erb, P., Ji, J., Wernli, M., Kump, E., Glaser, A., and Buchner, S. A., Role of apoptosis in basal cell and squamous cell carcinoma formation. Immunol. Lett., 100, 68-72 (2005).
5. Ha, Y. W., Lim, S. S., Ha, I. J., Na, Y. C., Seo, J. J., Shin, H., Son, S. H., and Kim, Y. S., Preparative isolation of four ginsenosides from Korean red ginseng (steam-treated Panax ginseng C. A. Meyer), by high-speed counter-current chromatography coupled with evaporative light scattering detection. J. Chromatogr. A, 115, 137-144 (2007).
6. Kim, S. M., Lee, S. Y., Cho, J. S., Son, S. M., Choi, S. S., Yun, Y. P., Yoo, H. S., Yoon, D. D., Oh, K. W., Han, S. B., and Hong, J. T., Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB. Eur. J. Pharmacol., 631, 1-9 (2010).
7. Kim, Y. J., Kwon, H. C., Ko, H., Park, J. H., Kim, H. Y., Yoo, J. H., and Yang, H. O., Anti-tumor activity of the ginsenoside Rk1 in human hepatocellular carcinoma cells through inhibition of telomerase activity and induction of apoptosis. Biol. Pharm. Bull., 31, 826-830 (2008).
8. Latonen, L. and Laiho, M., Cellular UV damage responsesfunctions of tumor suppressor p53. Biochim. Biophys. Acta, 1755, 71-89 (2005).
9. Lee, J. G., Lee, Y. Y., Kim, S. Y., Pyo, J. S., Yun-Choi, H. S., and Park, J. H., Platelet antiaggregating activity of ginsenosides isolated from processed ginseng. Pharmazie, 64, 602-604 (2009).
10. Liu, T. G., Huang, Y., Cui, D. D., Huang, X. B., Mao, S. H., Ji, L. L., Song, H. B., and Yi, C., Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice. BMC Cancer, 9, 250 (2009).
11. O'Connor, P. M., Jackman, J., Bae, I., Myers, T. G., Fan, S., and Mutoh, M., Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res., 57, 4285-4300 (1997).
12. Park, I. H., Kim, N. Y., Han, S. B., Kim, J. M., Kwon, S. W., Kim, H. J., Park, M. K., and Park, J. H., Three new dammarane glycosides from heat processed ginseng. Arch. Pharm. Res., 25, 428-432 (2002).
13. Sato, K., Mochizuki, M., Saiki, I., Yoo, Y. C., Samukawa, K., and Azuma, I., Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2. Biol. Pharm. Bull., 17, 635-639 (1994).
14. Stretch, J. R., Gatter, K. C., Ralfkiaer, E., Lane, D. P., and Harris, A. L., Expression of mutant p53 in melanoma. Cancer Res., 51, 5976-5979 (1991).
15. Vousden, K. H. and Lane, D. P., p53 in health and disease. Nat. Rev. Mol. Cell Biol., 8, 275-283 (2007).
16. Wallace-Brodeur, R. R. and Lowe, S. W., Clinical implications of p53 mutations. Cell. Mol. Life Sci., 55, 64-75 (1999).
17. Wang, C. Z., Aung, H. H., Zhang, B., Sun, S., Li, X. L., He, H., Xie, J. T., He, T. C., Du, W., and Yuan, C. S., Chemopreventive effects of heat-processed Panax quinquefolius root on human breast cancer cells. Anticancer Res., 28, 2545-2551 (2008).